Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2

被引:8
|
作者
Wang, Qian [1 ]
Li, Zhiteng [1 ]
Guo, Yicheng [1 ]
Mellis, Ian A. [1 ,2 ]
Iketani, Sho [1 ]
Liu, Michael [1 ]
Yu, Jian [1 ]
Valdez, Riccardo [3 ]
Lauring, Adam S. [4 ]
Sheng, Zizhang [1 ]
Gordon, Aubree [7 ]
Liu, Lihong [1 ,5 ]
Ho, David D. [1 ,5 ,6 ]
机构
[1] Columbia Univ, Aaron Diamond AIDS Res Ctr, Vagelos Coll Phys & Surg, New York, NY 10032 USA
[2] Columbia Univ, Vagelos Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA
[3] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Internal Med, Div Infect Dis, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA
[5] Columbia Univ, Vagelos Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10032 USA
[6] Columbia Univ, Vagelos Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA
[7] Univ Michigan, Dept Epidemiol, Ann Arbor, MI USA
基金
美国国家卫生研究院;
关键词
Stronger antibody evasion; Higher viral receptor binding affinity; highest viral receptor; SPIKE;
D O I
10.1016/j.isci.2023.108254
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
SARS-CoV-2 Omicron BA.2.75 has diversified into multiple subvariants with additional spike mutations and several are expanding in prevalence, particularly CH.1.1 and BN.1. Here, we investigated the viral receptor affinities and neutralization evasion properties of major BA.2.75 subvariants actively circulating in different regions worldwide. We found two distinct evolutionary pathways and three newly identified mutations that shaped the virological features of these subvariants. One phenotypic group exhibited a discernible decrease in viral receptor affinities, but a noteworthy increase in resistance to antibody neutralization, as exemplified by CH.1.1, which is apparently as resistant as XBB.1.5. In contrast, a second group demonstrated a substantial increase in viral receptor affinity but only a moderate increase in antibody evasion, as exemplified by BN.1. We also observed that all prevalent SARS-CoV-2 variants in the circulation presently, except for BN.1, exhibit profound levels of antibody evasion, suggesting this is the dominant determinant of virus transmissibility today.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
    Gruell, Henning
    Vanshylla, Kanika
    Tober-Lau, Pinkus
    Hillus, David
    Sander, Leif Erik
    Kurth, Florian
    Klein, Florian
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (10): : 1422 - 1423
  • [2] Evasion of neutralising antibodies by omicron sublineage BA.2.75
    Sheward, Daniel J.
    Kim, Changil
    Fischbach, Julian
    Muschiol, Sandra
    Ehling, Roy A.
    Bjorkstrom, Niklas K.
    Hedestam, Gunilla B. Karlsson
    Reddy, Sai T.
    Albert, Jan
    Peacock, Thomas P.
    Murrell, Ben
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (10): : 1421 - 1422
  • [3] Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant
    Qu, Panke
    Evans, John P.
    Zheng, Yi-Min
    Carlin, Claire
    Saif, Linda J.
    Oltz, Eugene M.
    Xu, Kai
    Gumina, Richard J.
    Liu, Shan-Lu
    [J]. CELL HOST & MICROBE, 2022, 30 (09) : 1518 - +
  • [4] Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
    Uraki, Ryuta
    Iida, Shun
    Halfmann, Peter J.
    Yamayoshi, Seiya
    Hirata, Yuichiro
    Iwatsuki-Horimoto, Kiyoko
    Kiso, Maki
    Ito, Mutsumi
    Furusawa, Yuri
    Ueki, Hiroshi
    Sakai-Tagawa, Yuko
    Kuroda, Makoto
    Maemura, Tadashi
    Kim, Taksoo
    Mine, Sohtaro
    Iwamoto, Noriko
    Li, Rong
    Liu, Yanan
    Larson, Deanna
    Fukushi, Shuetsu
    Watanabe, Shinji
    Maeda, Ken
    Wang, Zhongde
    Ohmagari, Norio
    Theiler, James
    Fischer, Will
    Korber, Bette
    Imai, Masaki
    Suzuki, Tadaki
    Kawaoka, Yoshihiro
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [5] Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
    Saito, Akatsuki
    Tamura, Tomokazu
    Zahradnik, Jiri
    Deguchi, Sayaka
    Tabata, Koshiro
    Anraku, Yuki
    Kimura, Izumi
    Ito, Jumpei
    Yamasoba, Daichi
    Nasser, Hesham
    Toyoda, Mako
    Nagata, Kayoko
    Uriu, Keiya
    Kosugi, Yusuke
    Fujita, Shigeru
    Shofa, Maya
    Begum, Mst Monira
    Shimizu, Ryo
    Oda, Yoshitaka
    Suzuki, Rigel
    Ito, Hayato
    Nao, Naganori
    Wang, Lei
    Tsuda, Masumi
    Yoshimatsu, Kumiko
    Kuramochi, Jin
    Kita, Shunsuke
    Sasaki-Tabata, Kaori
    Fukuhara, Hideo
    Maenaka, Katsumi
    Yamamoto, Yuki
    Nagamoto, Tetsuharu
    Asakura, Hiroyuki
    Nagashima, Mami
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Ueno, Takamasa
    Schreiber, Gideon
    Takaori-Kondo, Akifumi
    Shirakawa, Kotaro
    Sawa, Hirofumi
    Irie, Takashi
    Hashiguchi, Takao
    Takayama, Kazuo
    Matsuno, Keita
    Tanaka, Shinya
    Ikeda, Terumasa
    Fukuhara, Takasuke
    Sato, Kei
    [J]. CELL HOST & MICROBE, 2022, 30 (09) : 1540 - +
  • [6] Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75
    Wang, Qian
    Iketani, Sho
    Li, Zhiteng
    Guo, Yicheng
    Yeh, Andre Yanchen
    Liu, Michael
    Yu, Jian
    Sheng, Zizhang
    Huang, Yaoxing
    Liu, Lihong
    Ho, David D.
    [J]. CELL HOST & MICROBE, 2022, 30 (09) : 1512 - +
  • [7] Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
    Ryuta Uraki
    Shun Iida
    Peter J. Halfmann
    Seiya Yamayoshi
    Yuichiro Hirata
    Kiyoko Iwatsuki-Horimoto
    Maki Kiso
    Mutsumi Ito
    Yuri Furusawa
    Hiroshi Ueki
    Yuko Sakai-Tagawa
    Makoto Kuroda
    Tadashi Maemura
    Taksoo Kim
    Sohtaro Mine
    Noriko Iwamoto
    Rong Li
    Yanan Liu
    Deanna Larson
    Shuetsu Fukushi
    Shinji Watanabe
    Ken Maeda
    Zhongde Wang
    Norio Ohmagari
    James Theiler
    Will Fischer
    Bette Korber
    Masaki Imai
    Tadaki Suzuki
    Yoshihiro Kawaoka
    [J]. Nature Communications, 14
  • [8] A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
    Huo Jiandong
    Dijokaite-Guraliuc, Aiste
    Liu Chang
    Zhou Daming
    Ginn, Helen M.
    Das, Raksha
    Supasa, Piyada
    Selvaraj, Muneeswaran
    Nutalai, Rungtiwa
    Tuekprakhon, Aekkachai
    Duyvesteyn, Helen M. E.
    Mentzer, Alexander J.
    Skelly, Donal
    Ritter, Thomas G.
    Amini, Ali
    Bibi, Sagida
    Adele, Sandra
    Johnson, Sile Ann
    Paterson, Neil G.
    Williams, Mark A.
    Hall, David R.
    Plowright, Megan
    Newman, Thomas A. H.
    Hornsby, Hailey
    de Silva, Thushan, I
    Temperton, Nigel
    Klenerman, Paul
    Barnes, Eleanor
    Dunachie, Susanna J.
    Pollard, Andrew J.
    Lambe, Teresa
    Goulder, Philip
    Fry, Elizabeth E.
    Mongkolsapaya, Juthathip
    Ren, Jingshan
    Stuart, David I.
    Screaton, Gavin R.
    [J]. CELL REPORTS, 2023, 42 (01):
  • [9] Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75
    Cao, Yunlong
    Song, Weiliang
    Wang, Lei
    Liu, Pan
    Yue, Can
    Jian, Fanchong
    Yu, Yuanling
    Yisimayi, Ayijiang
    Wang, Peng
    Wang, Yao
    Zhu, Qianhui
    Deng, Jie
    Fu, Wangjun
    Yu, Lingling
    Zhang, Na
    Wang, Jing
    Xiao, Tianhe
    An, Ran
    Liu, Lu
    Yang, Sijie
    Niu, Xiao
    Gu, Qingqing
    Shao, Fei
    Hao, Xiaohua
    Meng, Bo
    Gupta, Ravindra Kumar
    Jin, Ronghua
    Wang, Youchun
    Xie, Xiaoliang Sunney
    Wang, Xiangxi
    [J]. CELL HOST & MICROBE, 2022, 30 (09) : 1527 - +
  • [10] Comparative neutralisation profile of SARS-CoV-2 omicron subvariants BA.2.75 and BA.5
    Tan, Chee-Wah
    Lim, Beng-Lee
    Young, Barnaby E.
    Yeoh, Aileen Ying-Yan
    Yung, Chee-Fu
    Yap, Wee-Chee
    Althaus, Thomas
    Chia, Wan-Ni
    Zhu, Feng
    Lye, David Chien
    Wang, Lin-Fa
    [J]. LANCET MICROBE, 2022, 3 (12): : E898 - E898